Impact of Pharmacist in Cardiology Service

Overview

The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his treatment. Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge. By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .

Full Title of Study: “Presence of a Clinical Pharmacist in a Cardiology Department: What Impact on the Management of Diabetic Patients Within Care Pathways? Example of Inpatient Cardiac Patients at GHPSJ”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 28, 2017

Interventions

  • Other: pharmacist assessment
    • St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization

Arms, Groups and Cohorts

  • Other: pharmacist assessment intervention group
    • St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization

Clinical Trial Outcome Measures

Primary Measures

  • Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
    • Time Frame: 5 days

Participating in This Clinical Trial

Inclusion Criteria

  • Diabetes type 2 patient hospitalized in cardiology service – Hospitalization more than 24 hours – with insuline or/and oral anti diabetic Exclusion Criteria:

  • diabètes type 1 – iatrogenic hyperglycaemia – hospitalization for cardia angiography

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fondation Hôpital Saint-Joseph
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Romain CADOR, MD, Principal Investigator, GHPSJ

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.